Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study of Management of Severe Tricuspid Regurgitation With Transcatheter Mitral Valve Clamping System

NCT04921605 is registered in ClinicalTrials.gov with Hangzhou Valgen Medtech Co., Ltd as lead sponsor.

NCT NCT04921605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04921605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study of Management of Severe Tricuspid Regurgitation With Transcatheter Mitral Valve Clamping System
Lead sponsor
Hangzhou Valgen Medtech Co., Ltd
Phase
Not applicable
Overall status
Unknown status
Start date
December 15, 2020
Completion date
June 15, 2023
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tricuspid regurgitation